11/22/2023 0 Comments Rgis inventory services![]() regulators cleared Mounjaro as a type-2 diabetes treatment last year, and they're expected to expand its use to include obesity by year-end. Eli Lilly's leading GLP-1 is called Mounjaro, and unlike Wegovy and Ozempic, it targets a second hormone involved in blood-sugar control. Novo also sells a GLP-1 called Ozempic that's approved in the U.S. Wegovy belongs to a class of incretin drugs known broadly as GLP-1s, which mimic a gut hormone that, when released, can suppress appetite. Currently, Wall Street estimates Wegovy's 2023 sales to be $4.46 billion, according to FactSet, rising to $7.76 billion in 2024. The firm's analysts said that, if not for supply shortages, sales of Novo's obesity therapy, Wegovy, would have likely topped $7 billion in the U.S. Insurance reimbursement for obesity drugs has spread quicker than Morgan Stanley expected, which helped prompt the firm to update its multiyear sales outlook. "The enormous supply chain investments Novo and Lilly are making today will create significant barriers to entry in the future," the firm wrote. And despite increasing competition from other pharmaceutical companies, Morgan Stanley analysts expect Club name Eli Lilly and rival Novo Nordisk (NVO) to remain the leading weight-loss players, with a combined market share around 82% over the long term. The news: Obesity drugs could generate annual sales up to $77 billion in 2030, Morgan Stanley said Friday, a nearly 43% increase to the firm's previous forecast. LLY YTD mountain Eli Lilly (LLY) year-to-date performance. ![]() Here's our full take on the headlines and their implications for our investments in the three companies. ![]() Meanwhile, commentary from one of Danaher 's (DHR) competitors is sending shares of the Club holding surging Friday, while the top boss at one of our chipmakers offered reassuring remarks around managing geopolitical risks. Morgan Stanley analysts believe the market for obesity drugs is even larger than initially expected, a finding that aligns with our rosy outlook on Eli Lilly (LLY). Personal Loans for 670 Credit Score or Lower Personal Loans for 580 Credit Score or Lower Best Debt Consolidation Loans for Bad Credit ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |